Use of serotonergic antidepressants and St John's wort in older Australians: A population-based cohort study
Date
2013
Authors
Rahman, S.
Basilakis, J.
Rahmadi, A.
Lujic, S.
Musgrave, I.
Jorm, L.
Hay, P.
Munch, G.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Australasian Psychiatry, 2013; 21(3):262-266
Statement of Responsibility
Syed Ziaur Rahman, Jim Basilakis, Anton Rahmadi, Sanja Lujic, Ian Musgrave, Louisa Jorm, Phillipa Hay, Gerald Münch
Conference Name
Abstract
OBJECTIVE: The study investigated the use of serotonergic antidepressants (SSRIs: selective serotonin reuptake inhibitors; SNRIs: serotonin–norepinephrine reuptake inhibitors) and St John’s wort in a large NSW-based community sample, and sought to identify a potentially dangerous concomitant use of these medications. METHODS: Cross-sectional data from 266,848 participants from the ‘45 and Up’ study were used. The questionnaire captures self-reported treatment for depression or anxiety and antidepressant medications in the last four weeks. RESULTS: 5.8% of participants received treatment for depression or anxiety, with 4.7% taking an SSRI and 1.3% an SNRI. St John’s wort was taken by 0.3% of the participants. Use of SSRIs and SNRIs was reported more frequently by females than males (respectively, 64.1% vs 35.9%, 66.9% vs 33.1%). The gender difference was even more pronounced for St John’s wort (75.6% vs. 24.4%). Use of antidepressants decreased after the age of 65 years. One hundred and forty people reported concurrent use of an SSRI and an SNRI, and 11 people of an SSRI with St John’s wort. CONCLUSIONS: Around 7% of the study population aged 45–65 years reported the use of SSRIs or SNRIs, decreasing to 5% above 70 years of age. It is of concern that some individuals used an SSRI concurrently with St John’s wort.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
© The Royal Australian and New Zealand College of Psychiatrists 2013